Fundz
Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Orchestra Life Sciences Appoints Charles Conroy As Chief Operating Officer

PRIVATEAug 18, 2026•about 3 hours ago

Position

Chief Operating Officer

Company

Orchestra Life Sciences

Charles Conroy
Creve CoeurManufacturingBiotechnologyHealth Care

Description

Orchestra Life Sciences has announced the appointment of Charles Conroy as Chief Operating Officer. Conroy brings over 25 years of leadership experience in the radiopharmaceutical and healthcare sectors.

Company Information

Company

Orchestra Life Sciences

Location

Creve Coeur, Missouri, United States

About

Orchestra Life Sciences (OLS) is a technical consultancy providing strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare diseases. The company specializes in engineering solutions, operational excellence, and quality compliance services for advanced therapy manufacturing facilities. Their comprehensive approach encompasses facility design, process optimization, and implementation of cutting-edge manufacturing technologies. With a focus on innovation and efficiency, OLS helps clients navigate complex technical challenges while maintaining the highest standards of quality and regulatory compliance.

Don't miss Orchestra Life Sciences's next move

Get an email the moment Orchestra Life Sciences changes its leadership, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Orchestra Life Sciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.